Hormonal therapy for metastatic renal cell carcinoma combined androgen and provera followed by high dose tamoxifen
- 1 January 1993
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (7) , 997-999
- https://doi.org/10.1016/s0959-8049(05)80209-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Circadian-shaped infusions of floxuridine for progressive metastatic renal cell carcinoma.Journal of Clinical Oncology, 1990
- Treatment of metastatic renal cell carcinoma with coumarin (1,2-benzopyrone) and cimetidine: a pilot study.Journal of Clinical Oncology, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Clinical toxicity of interferons in cancer patients: a review.Journal of Clinical Oncology, 1986
- Treatment of Advanced Renal Cell Carcinoma—Traditional Methods and Innovative ApproachesJournal of Urology, 1983
- High-dose tamoxifen in metastatic renal cell carcinomaUrology, 1982
- Hormone receptors in renal cell carcinomaCancer Chemotherapy and Pharmacology, 1981
- Renal cell carcinomaThe Lancet Healthy Longevity, 1977
- Chemotherapy of adenocarcinoma of the kidneyCancer, 1973
- Hormones and the Kidney: Possible Therapeutic Role of Testosterone in a Patient with Regression of Metastases from Renal AdenocarcinomaBMJ, 1964